Genome-wide studies define new genetic mechanisms of IgA vasculitis

Lili Liu,Li Zhu,Sara Monteiro-Martins,Aaron Griffin,Lukas J. Vlahos,Masashi Fujita,Cecilia Berrouet,Francesca Zanoni,Maddalena Marasa,Jun Y. Zhang,Xu-jie Zhou,Yasar Caliskan,Oleh Akchurin,Samhar Al-Akash,Augustina Jankauskiene,Monica Bodria,Aftab Chishti,Ciro Esposito,Vittoria Esposito,Donna Claes,Vladimir Tesar,Thomas K. Davis,Dmitry Samsonov,Dorota Kaminska,Tomasz Hryszko,Gianluigi Zaza,Joseph T. Flynn,Franca Iorember,Francesca Lugani,Dana Rizk,Bruce A. Julian,Guillermo Hidalgo,Mahmoud Kallash,Luigi Biancone,Antonio Amoroso,Luisa Bono,Laila-Yasmin Mani,Bruno Vogt,Fangming Lin,Raji Sreedharan,Patricia Weng,Daniel Ranch,Nianzhou Xiao,Alejandro Quiroga,Raed Bou Matar,Michelle Rheault,Scott Wenderfer,Dave Selewski,Sigrid Lundberg,Cynthia Silva,Sherene Mason,John D. Mahan,Tetyana Vasylyeva,Krzysztof Mucha,Bartosz Foroncewicz,Leszek Pączek,Michał Florczak,Małgorzata Olszewska,Agnieszka Grańdziska,Maria Szczepańska,Edyta Machura,Andrzej Badeński,Helena Krakowczyk,Przemysław Sikora,Norbert Kwella,Monika Miklaszewska,Dorota Drożdż,Marcin Zaniew,Krzysztof Pawlaczyk,Katarzyna Siniewicz-Luzeńczyk,Andrew S. Bomback,Gerald B. Appel,Claudia Izzi,Francesco Scolari,Anna Materna-Kiryluk,Malgorzata Mizerska-Wasiak,Laureline Berthelot,Evangeline Pillebout,Renato C. Monteiro,Jan Novak,Todd Jason Green,William Smoyer,M. Colleen Hastings,Robert J. Wyatt,Raoul Nelson,Javier Martin,Miguel A. González-Gay,Phillip De Jager,Anna Kottgen,Andrea Califano,Ali G. Gharavi,Hong Zhang,Krzysztof Kiryluk

DOI: https://doi.org/10.1101/2024.10.10.24315041

2024-10-11

Abstract:IgA vasculitis (IgAV) is a pediatric disease with skin and systemic manifestations. Here, we conducted genome, transcriptome, and proteome-wide association studies in 2,170 IgAV cases and 5,928 controls, generated IgAV-specific maps of gene expression and splicing from blood of 255 pediatric cases, and reconstructed myeloid-specific regulatory networks to define disease master regulators modulated by the newly identified disease driver genes. We observed significant association at the HLA-DRB1 (OR=1.55, P=1.1x10-25) and fine-mapped specific amino-acid risk substitutions in DRβ1. We discovered two novel non-HLA loci: FCAR (OR=1.51, P=1.0x10-20) encoding a myeloid IgA receptor FcαR, and INPP5D (OR=1.34, P=2.2x10-09) encoding a known inhibitor of FcαR signaling. The FCAR risk locus co-localized with a cis-eQTL increasing FCAR expression; the risk alleles disrupted a PRDM1 binding motif within a myeloid enhancer of FCAR. Another risk locus was associated with a higher genetically predicted levels of plasma IL6R. The IL6R risk haplotype carried a missense variant contributing to accelerated cleavage of IL6R into a soluble form. Using systems biology approaches, we prioritized IgAV master regulators co-modulated by FCAR, INPP5D and IL6R in myeloid cells. We additionally identified 21 shared loci in a cross-phenotype analysis of IgAV with IgA nephropathy, including novel loci PAID4, WLS, and ANKRD55.

What problem does this paper attempt to address?

The paper attempts to address the problem of defining new genetic mechanisms of IgA vasculitis (IgAV) through whole-genome, transcriptome, and proteome association studies. Specifically, the study aims to:

1. **Identify genetic loci associated with IgAV**: Through large-scale genome-wide association studies (GWAS), identify genetic variants significantly associated with the risk of developing IgAV.

2. **Explore the functional impact of these genetic loci**: Through transcriptome and proteome association studies (TWAS and PWAS), evaluate how these genetic variants affect gene expression and protein levels, thereby further understanding their role in disease development.

3. **Construct disease-specific gene expression and splicing maps**: By performing RNA sequencing on blood samples from 255 children with IgAV, generate disease-specific expression quantitative trait loci (eQTL) and splicing quantitative trait loci (sQTL) maps to better explain the impact of IgAV risk alleles.

4. **Reconstruct myeloid cell-specific regulatory networks**: Using single-cell transcriptome data, reconstruct myeloid cell-specific regulatory networks to identify key master regulators controlled by newly discovered disease-driving genes.

5. **Investigate the genetic relationship between IgAV and other diseases**: Through cross-phenotype analysis, compare shared and unique genetic loci between IgAV and IgA nephropathy (IgAN) to reveal genetic links and differences between the two conditions.

Through these studies, the paper aims to provide new insights into the pathogenesis of IgA vasculitis and offer a scientific basis for developing new therapeutic targets and prevention strategies.